Quantcast Lixte Biotechnology Holdings' Lead Compound, LB-1.2, Enhances The Effectiveness - Congoo
 
 
JOB MARKETS Log In
Lixte Biotechnology Holdings' Lead Compound, LB-1.2, Enhances the Effectiveness
Have an interest in this Story?
Sign Up for Real-Time email updates
KSLA  | July 03, 2009

EAST SETAUKET, N.Y., July 2 /PRNewswire-FirstCall/ -- Lixte Biotechnology Holdings announced today that investigators of the National Institute of Neurological Disorders and Stroke (NINDS) and the National Cancer Institute (NCI), National Institutes of Health and Lixte reported that its novel compou...
Read Full Article   
 
Leave a Comment: You must be logged in to leave a comment     Log in | Register
 

Featured Members
Leo Petrik Leo Petrik
Founder & CEO
Entrepreneur
David Hood David Hood
Director
Marketing/Public Relations

  
  View more profiles

 
Access dozens of premium and subscriptions sites Free! Download now.

Advertise   |   Build a News Circle   |   Get News Briefings   |   Congoo News Home   |   Get the Netpass
About Congoo   |   Terms   |   Privacy   |   Need Help?   |   Site Map
Copyright ©2009 Congoo.com. All Rights Reserved.